Issues
 | OBO ontology file | Unassigned | Unassigned |  | Unresolved | Jun 11, 2021 | Jun 11, 2021 | ||||
 | Elaboration on DRON-24: requesting more annotations on drugs for lung cancer | Unassigned | Unassigned | | Unresolved | Feb 2, 2021 | Feb 2, 2021 | ||||
| Immunotherapy treatment for advanced NSCLC | Unassigned | Unassigned |  | Unresolved | Jan 21, 2021 | Jan 21, 2021 | ||||
 | Missing: Paracetamol (CHEBI:46195) | Unassigned | Unassigned | | Fixed | Jul 13, 2020 | Aug 20, 2020 | ||||
| Assert disposition for drugs like Ambien/zolpidem with synonym "z-drugs" | Unassigned | Unassigned | | Unresolved | May 11, 2020 | May 11, 2020 | ||||
| add SNRI antidepressant disposition | Unassigned | Unassigned | | Unresolved | May 11, 2020 | May 11, 2020 | ||||
| ethacrynic acid should have "function-inhibiting Na-K-Cl cotransporter 2 (NKCC2) binding disposition" | Unassigned | William Hogan | | Fixed | May 18, 2016 | Sep 17, 2020 | ||||
| Add excipient classes from ingredients paper | Unassigned | William Hogan | | Fixed | Apr 30, 2016 | Aug 20, 2020 | Apr 30, 2016 | |||
| Add 'drug component' to DrOn | Unassigned | William Hogan | | Won't Fix | Apr 15, 2016 | Nov 19, 2020 | ||||
| Duplicate ingredients | Unassigned | William Hogan | | Fixed | Nov 21, 2013 | Sep 17, 2020 | ||||
 | Add RxNorm attribution | Unassigned | Unassigned | | Fixed | Jun 3, 2013 | Apr 4, 2014 | ||||
| move ontology annotations to bridge | Unassigned | Unassigned | | Fixed | Jun 3, 2013 | Apr 4, 2014 | ||||
| Request a PURL for DrOn | Unassigned | Unassigned | | Fixed | Jun 3, 2013 | Sep 20, 2013 | ||||
| atom shows up as child of material entity and chemical entity | Unassigned | Unassigned | | Fixed | Jun 3, 2013 | Apr 4, 2014 | ||||
| Remove disposition from cromoglicic acid | Unassigned | Unassigned | | Fixed | Jun 3, 2013 | Oct 25, 2013 | ||||
| lamotrigine is coming up as calcium channel blocker and it is not | Unassigned | William Hogan | | Fixed | Jun 3, 2013 | Aug 26, 2016 | ||||
| Represent placebo in DrOn | Unassigned | William Hogan | | Fixed | Jun 3, 2013 | Oct 15, 2020 | ||||
| Add CYP2C19 dispositions and assign to relevant molecule types | Unassigned | William Hogan | | Fixed | Jun 3, 2013 | Aug 26, 2016 | ||||
| duplicate NDCs | Unassigned | William Hogan | | Fixed | Jun 3, 2013 | Aug 26, 2016 | ||||
| Move capsules, tablets, ointments, creams, lotions, etc. below the appropriate drug product subtype | Unassigned | William Hogan | | Fixed | Jun 3, 2013 | Aug 26, 2016 |
1-20 of 20